Gilbert Omenn

Shares of Esperion Therapeutics Inc (NASDAQ: ESPR) surged higher by more than 13 percent on Wednesday after the company's director, Gilbert Omenn, disclosed an insider purchase of 5,000 shares of company stock. Omenn disclosed in a regulatory filing he bought 5,000 shares of Esperion's stock on...